Your cart is currently empty!
Vaccine
Manufacturers of oral and parenteral vaccines of viral and non viral prophylaxis Our vaccine business is our rapidly growing division producing, marketing, and distributing several 100 million vaccines globally.
Consumer Care
Our consumer healthcare division provides the latest in all-natural healthcare brands specifically designed to meet increased demands for natural products and remedies.
Nutraceuticals
Portfolio of products comprising dietary supplements, sports nutrition products, functional foods, vitamins, minerals, and weight loss products.
Generic Medicines
We manufacture a vast number of generic medicines that address numerous conditions from acute to chronic illnesses.
Welcome to Anzalp Pharmasolutions Pvt. Ltd.
Anzalp Pharmasolutions is a leading global healthcare / pharmaceutical company with a strong emphasis on precision medicine and nutrition.
ACCESS
Our number one goal is to provide access to medicines and nutraceuticals and positively impact the lives of all those whom we serve with the skill, dedication, and professionalism of our physicians, experienced scientists, analysts, technicians and support staff. We will strive for continuous quality improvement, in an ethical, empathetic and innovative manner.
GOVERNANCE
Anzalp is committed to operating at the highest level of governance in all that we do.
SUSTAINABILTIY
We continuously strive to reduce our e our impact on the environment. Our focus is to reduce our consumption of natural resources and minimize the effects of climate change. We are focused on reduction of our contribution to GHGs by modernizing our chemical processes and equipment. We have a deep commitment to preserving the environment while improving the lives of our consumers.
Anzalp News
March 20th, 2020 – Anzalp Partners with vendors in Southeast Asia to provide a non-stop supply of vaccines across the globe.
October 1st, 2020 – Anzalp R&D invents a new isomorph of an anti-retroviral during lockdown to fight against Coronavirus
Jan. 7th, 2021 – Anzalp receives the US Patent of WORLD’S FIRST soluble version of Remdesivir.
Sixty Year Old Network of Peers, Employees, Clients and Stakeholders gives us a robust presence across the globe.
20K
COLLEAGUES
Men and women, committed to better protect you around the world
45
СOUNTRIES
Where you will find the same quality of products and dedication around the world
25M
CLIENTS
Making us one of the leading pharmasolution around the globe
Committed to creating a highly stimulating workplace that appreciates and acknowledges diligence, encourages team spirit and spurs innovation and creativity.